[Ip-health] MSF/DNDi webinar (Friday, Feb 26): TRIPS waiver for COVID19 tools-- what are the implication for Africa?
Yuanqiong.HU at geneva.msf.org
Tue Mar 2 04:41:06 PST 2021
Please kindly find below the recording of this webinar: https://www.youtube.com/watch?v=cEF4mhwknjM for your reference.
From: Ip-health <ip-health-bounces at lists.keionline.org> on behalf of Yuanqiong HU <Yuanqiong.HU at geneva.msf.org>
Sent: Thursday, February 25, 2021 6:55 PM
To: ip-health at lists.keionline.org <Ip-health at lists.keionline.org>
Subject: [Ip-health] MSF/DNDi webinar (Friday, Feb 26): TRIPS waiver for COVID19 tools-- what are the implication for Africa?
Title: TRIPS waiver for COVID19 Tools – what are the implications for Africa?
On 2 October 2020, India and South Africa asked the World Trade Organization (WTO) to allow all countries to choose to neither grant nor enforce patents and other intellectual property (IP) rights related to COVID-19 drugs, vaccines, diagnostics, and other technologies for the duration of the pandemic, until global herd immunity is achieved.
All governments are facing challenges ensuring timely, sufficient, and affordable access to effective medicines, vaccines, diagnostics, and other essential medical tools. This is especially challenging, for many developing countries, including African nations, that face limitations developing and scaling up manufacturing capacity due to IP barriers. The unprecedented situation today requires that all IP, knowledge, technology, and data related to COVID19 health technologies can be utilised by everyone to ensure uninterrupted production and supply by any competent country or manufacturer worldwide. To achieve this, governments have a collective responsibility to address IP and technology barriers. Governments need to fulfil their core obligations of protecting public health and ensuring access to medicines for all. The waiver proposal by India and South Africa presents an important opportunity for all governments to unite and stand up for public health, global solidarity, and equitable access through a concrete step at the international level that can provide an automatic and expedited solution to address IP and technology challenges collectively.
Please join us for a webinar, hosted by Médecins Sans Frontières (MSF) and Drugs for Neglected Diseases Initiative (DNDi), to discuss the implications of the TRIPs waiver proposal for Africa, and why countries should support it.
Mustaqeem De Gama - Counsellor, the Permanent Mission of South Africa in Geneva.
Dr Hu Yuan Qiong - Senior Legal & Policy Advisor,Médecins Sans Frontières Access Campaign
Dr Ahmed Ogwell Ouma - Deputy Director, Africa CDC
Moses Mulumba - Executive Director, CEHURD
Dr Monique Wasunna – Director, DNDi Africa Region (Closing remarks)
Spring Gombe - Programme Manager for Technology Access Partnership at UN Technology Bank for the Least Developed Countries (Moderator)
When: Friday 26th February 2021, 14:00 – 15:30 EAT
Please register at the following link: https://doctorswithoutborders.zoom.us/webinar/register/WN_wFo2m47PSGmRHy_Lhprt1g.
Ip-health mailing list
Ip-health at lists.keionline.org
More information about the Ip-health